Benchmark Reiterates Speculative Buy Rating on Anebulo Pharmaceuticals (ANEB)
Tweet Send to a Friend
(Updated - February 25, 2025 10:28 AM EST)
Benchmark analyst Robert Wasserman reiterated a Speculative Buy rating and $8.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Robert Wasserman reiterated a Speculative Buy rating and $8.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
